Staff20192020202120222023
Personnel at the end of the year----676
Staff turnover in EUR----227,386
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)13.6413.6515.79139.1520.84
Dividend per share-----
Basic earnings per share-0.02-0.71-0.75-1.24-0.73
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover126.2110.3348.1361.3153.7
Operating income (EBIT)-6.3-64.5-75.2-141.4-83.3
Earnings before taxes-8.8-75.1-91.9-160.2-105.4
Annual net profit/ loss-1.7-64.4-73.4-143.3-101.4
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets129.2308.4585.8424.7262.8
Total fixed assets145.0151.4240.2207.9206.6
Total assets274.1459.8826.0632.6469.4
Liabilities
Total short-term liabilities41.3175.9369.0277.4158.9
Total long-term liabilities97.7206.5286.5135.4182.3
Total provisions0.42.48.31.31.1
Equity capital135.277.4170.6219.8128.2
Total liabilities274.1459.8826.0632.6469.4
Management:
Thomas Lingelbach
Dipal Patel
Franck Grimaud
Frederic Jacotot
Juan Carlos Jaramillo
Peter Bühler
Petra Pesendorfer
Vincent Dequenne
Board:
Anne-Marie Graffin
Kathrin Jansen
James Connolly
James Sulat
Maïlys Ferrère
Shareholding in %:
BlackRock Fund Advisors 1.09
Bpifrance Participations SA /PRIVATE EQUITY/ 6.22
CDC Croissance SA 1.49
Deep Track Capital LP 4.99
Groupe Grimaud La Corbière SA 8.73
Medical Strategy GmbH 1.06
Norges Bank Investment Management 1.03
Pfizer Inc. 6.87
Polar Capital LLP 3.61
The Vanguard Group, Inc. 2.58
Freefloat 62.32
Address: Campus Bio-Ouest, 6, rue Alain Bombard, 44800 Saint-Herblain
T: +33-2-28-07-37-10
F: +
I: http://www.valneva.com
E: info@valneva.com